Lexaria extends pharmaceutical partnership through december 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PCVX
2. PTC
3. NVDA
4. SPY
5. META
6. MSFT
7. GMAB
8. BBIO
9. BETR
10. USO

Go back to Lexaria extends pharmaceutical partnership through december 2026

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

April 29, 2026 9:10 AM EDT

KELOWNA, BC / ACCESS Newswire / April 29, 2026 / Lexaria Bioscience Corp. (NASDAQ: LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, provides this update on the Material Transfer Agreement ("MTA") originally entered into on August 30, 2024 with a pharmaceutical company ("PharmaCO") to evaluate Lexaria's DehydraTECH technology in a pre-clinical setting.

The original agreement has been successfully extended through December 31, 2026, to accommodate time required for PharmaCO's receipt and review of Lexaria's 2026... More